DNA N7-guanine residues (N7-G)

DNA N7-guanine residues represent the most nucleophilic sites within the human genome, serving as a critical molecular target for several major classes of chemotherapy, including platinum-based agents and nitrogen mustards (NIH, PubChem). The N7 nitrogen atom of the guanine base is strategically located and exposed in the major groove of the DNA double helix, making it highly accessible to electrophilic drug molecules. When drugs like cisplatin or cyclophosphamide bind to this site, they form stable covalent or coordination adducts that significantly distort the DNA's structural integrity. These lesions act as physical barriers to essential cellular machinery, effectively halting DNA replication and RNA transcription in rapidly proliferating malignant cells. While this mechanism is a cornerstone of cancer treatment, the non-specific modification of N7-guanine in healthy tissues can lead to significant systemic toxicities, such as bone marrow suppression and the risk of developing secondary cancers due to the mutagenic potential of unrepaired DNA adducts (PMID: 15141361, PMID: 17013111).

Other names

Guanine N7N7-position of guanineN7-deoxyguanosineN7-alkylguanine site

Antineoplastic drugs target the N7 position of guanine through covalent alkylation or coordination complex formation. This chemical modification leads to the formation of DNA adducts and cross-links (both intrastrand and interstrand) that physically block the progression of DNA and RNA polymerases, thereby inhibiting DNA replication and transcription and ultimately triggering programmed cell death or apoptosis (PMID: 17013111, PMID: 15141361).